Damora Therapeutics (DMRA) Exchange Rate Effect (2019 - 2026)
Damora Therapeutics (DMRA) posted Exchange Rate Effect of -$48000.0 for Q1 2026, down 166.67% on a QoQ basis from -$18000.0 in Q4 2025, and down 123.65% year-over-year from $203000.0 in Q1 2025.
Damora Therapeutics (DMRA) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Damora Therapeutics' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$48000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 123.65% year-over-year to -$48000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $454000.0 (up 1846.15% YoY) and the FY2025 annual result came in at $705000.0, up 322.4% from the prior year.
- Exchange Rate Effect was -$48000.0 for Q1 2026 at Damora Therapeutics, down from -$18000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.5 million in Q4 2022 and bottomed at -$720000.0 in Q2 2022.
- A 5-year average of $58117.6 and a median of -$18000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 949.15% — and 2024, when it plunged 563.16%.
- Damora Therapeutics' Exchange Rate Effect stood at $1.5 million in 2022, then slumped by 81.3% to $281000.0 in 2023, then slumped by 301.78% to -$567000.0 in 2024, then soared by 96.83% to -$18000.0 in 2025, then slumped by 166.67% to -$48000.0 in 2026.
- Business Quant data shows DMRA's Exchange Rate Effect at -$48000.0 in Q1 2026, -$18000.0 in Q4 2025, and $11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | -48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48,000.00 |
| Mar 31, 2026 | -48,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | 467,000.00 |
| Sep 30, 2024 | 467,000.00 |
| Jun 30, 2024 | -129,000.00 |
| Jun 30, 2024 | -129,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Dec 31, 2023 | 281,000.00 |
| Dec 31, 2023 | 281,000.00 |